Vertex Pharmaceuticals (NASDAQ: VRTX) Soars: Strong CF Performance and Promising Kidney Drug Pipeline Drive UBS Price Target Hike
| Show full article |
|
This functionality is available for registred users only
|
-
Full nameUBS Group AG
-
Registration countrySwitzerland
-
IndustryBanks
-
М/S&P/F
*** /*** /***









